White House discusses reimportation with drug industry

07/7/2009 | Wall Street Journal, The

White House officials assured the drug industry that drug reimportation will not be necessary once a health care bill that promises larger cost savings is passed, said Billy Tauzin, president of the Pharmaceutical Research and Manufacturers of America. Tauzin was among the industry representatives meeting at the White House to discuss a cost-savings agreement reached last month with health care negotiators.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC